News | Embolization devices | December 17, 2015

ArtVentive Medical Testing Next-Generation EOS Vessel Occlusion Technology

Upgraded device features reduced profile, reversibility for immediate and permanent vessel occlusion in arterial and venous settings

December 17, 2015 — ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.

According to ArtVentive President and CTO Leon Rudakov, Ph.D., the second-generation EOS device offers several advantages, including profile reductions, reversibility, enhanced control over deployment and the opportunity to advance into new indications.

The ArtVentive EOS is a catheter-based, self-expandable device, which facilitates permanent and immediate occlusion of peripheral vessels. The device is designed to serve as a safe and reliable alternative to major surgery in certain cases.

For more information: www.artventivemedical.com

Related Content

Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
News | Cath Lab

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
Subscribe Now